LIPO
LIPELLA PHARMS INCstockOTC
EODNov 17, 2026
0.0004USD-33.333%(-0.0002)1,205
LIPO Financials
In Q3 FY 2025 (ended ), LIPELLA PHARMS INC (LIPO) reported revenue of $0, net income of −$1.25M, operating cash flow of −$926.06K, and assets of $2.35M (filed ).
Loading business breakdowns…